PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

Search

READY CAPITAL CORP

Cerrado

SectorInmobiliario

4.17 0.72

Resumen

Variación precio

24h

Actual

Mínimo

4.12

Máximo

4.19

Métricas clave

By Trading Economics

Ingresos

380M

82M

Ventas

-101M

-74M

Rentabilidad por dividendo

20.69

Margen de beneficio

-111.221

Empleados

475

EBITDA

380M

82M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+18.75% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

20.69%

6.00%

Próximas Ganancias

7 ago 2025

Fecha Próximo Dividendo

30 oct 2025

Próxima Fecha de Ex Dividendo

29 sept 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

28M

766M

Apertura anterior

3.45

Cierre anterior

4.17

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

40 / 189 Clasificación en Real estate

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

READY CAPITAL CORP Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2025, 21:42 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Ganancias
Principales Movimientos del Mercado

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Ganancias

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

Principales Movimientos del Mercado

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Charlas de Mercado

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Charlas de Mercado

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Ganancias

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Ganancias

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Ganancias

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Ganancias

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Charlas de Mercado

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Charlas de Mercado

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Charlas de Mercado

Gold Climbs on Rate Cut Speculation -- Market Talk

Comparación entre iguales

Cambio de precio

READY CAPITAL CORP Esperado

Precio Objetivo

By TipRanks

18.75% repunte

Estimación a 12 meses

Media 4.94 USD  18.75%

Máximo 6 USD

Mínimo 4.25 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para READY CAPITAL CORP Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

0

Comprar

3

Mantener

1

Vender

Puntuación técnica

By Trading Central

4.37 / 4.45Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

No Evidence

Largo Plazo

No Evidence

Sentimiento

By Acuity

40 / 189 Clasificación en Inmobiliario

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de READY CAPITAL CORP

Ready Capital Corporation operates as a real estate finance company in the United States. It operates through two segments: LMM Commercial Real Estate and Small Business Lending. The company originates, acquires, finances, and services lower-to-middle-market (LLM) commercial real estate loans, small business administration (SBA) loans, residential mortgage loans, construction loans, and mortgage-backed securities collateralized primarily by LLM loans, or other real estate-related investments. The LMM Commercial Real Estate segment originates LLM loans across the full life-cycle of an LLM property, including construction, bridge, stabilized, and agency loan origination channels. The Small Business Lending segment acquires, originates, and services owner-occupied loans guaranteed by the SBA under its SBA Section 7(a) Program; and acquires purchased future receivables. The company has elected to be taxed as a real estate investment trust (REIT) and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Sutherland Asset Management Corporation and changed its name to Ready Capital Corporation in September 2018. Ready Capital Corporation was founded in 2007 and is headquartered in New York, New York.